For instance, inhibiting the DNA damage response (DDR) kinase ATM has recently been shown to inhibit myofibroblastic features, increase immune infiltration and sensitize to immune checkpoint therapy in subcutaneous tumor models (Mellone et al, 2022). Here, ATM is linked to neoplasm.